/SGRY

Surgery Partners Inc

SGRY

$14.38USD↑+1.84%+0.26 today

MARKET CAP

1.9B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$14 – $15

52W RANGE

$11

$23

AI Summary

Stalk

StalkMedium

Despite a persistent long-term downtrend and price below key moving averages, the chart’s Bearish Exhaustion pattern in an oversold context grants a medium-term bullish mean-reversion bias. Short-term execution lacks clear entry while price consolidates around the 9/20 EMAs, warranting patience and stalking pullbacks into the $13.80–$14.00 support zone ahead of a potential reversal bounce.

↑Analysts rate SGRY Moderate Buy with $19.45 PT, implying +37.8% upside
↑High earnings yield (~57%) suggests attractive valuation
↓Weak profitability metrics highlight margin and cash flow concerns

Full analysis →

Buying

7

institutions

Selling

6

institutions

New Positions

3

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
JH Janus Henderson Group Plc Q1 2026	BUY	27.08 M	322.80 M	+13.54 M	+54.3%	0.08%
BI Blackrock, Inc. Q2 2026	BUY	6.24 M	104.86 M	+580.72 K	+55.4%	0.00%
TR T. Rowe Price Investment Management, Inc. Q2 2026	BUY	5.92 M	99.39 M	+3.97 M	+327.7%	0.07%
OC Oaktree Capital Management LP Q2 2026	BUYNEW	862.59 K	14.49 M	+862.59 K	+0.0%	0.26%
MG Man Group Plc Q2 2026	SELL	697.55 K	11.72 M	+-248.97 K	+3.9%	0.02%
CA Citadel Advisors LLC Q2 2026	SELL	475.68 K	7.99 M	+-1.78 M	-70.2%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	320.29 K	5.37 M	+-16.10 K	+37.5%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUYNEW	130.10 K	2.19 M	+130.10 K	+0.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	64.38 K	1.08 M	+64.38 K	+0.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	46.16 K	775.40 K	+34.20 K	+444.2%	0.00%
GC Glenview Capital Management, LLC Q2 2026	SELL	0.00	0.00	+-1.80 M	-100.0%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-648.84 K	-100.0%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	SELL	0.00	0.00	+-20.00 K	-100.0%	0.00%